NeuroPace (NPCE) Shares Outstanding (Diluted Average) (2020 - 2026)

NeuroPace has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $33.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 7.1% year-over-year to $33.7 million; the trailing twelve-month figure through Mar 2026 stood at $33.7 million (up 7.1% YoY), and the FY2025 full-year result was $32.7 million, up 12.35% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $33.7 million, up from $32.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $33.7 million in Q1 2026, with the low at $24.3 million in Q1 2022.
• Average Shares Outstanding (Diluted Average) over 5 years is $28.2 million, with a median of $28.3 million recorded in 2024.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 8930.26% in 2022, while the deepest fall reached 1.72% in 2022.
• Tracing NPCE's Shares Outstanding (Diluted Average) over 5 years: stood at $24.6 million in 2022, then increased by 5.11% to $25.9 million in 2023, then rose by 12.67% to $29.1 million in 2024, then climbed by 12.35% to $32.7 million in 2025, then grew by 3.04% to $33.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $33.7 million (Q1 2026), $32.7 million (Q4 2025), and $33.1 million (Q3 2025), per Business Quant data.

Peer Comparison